Jeffrey Brent
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Overdose | 29 | 2026 | 381 | 3.550 |
Why?
| | Poisoning | 21 | 2025 | 119 | 3.490 |
Why?
| | Toxicology | 14 | 2025 | 49 | 2.610 |
Why?
| | Analgesics, Opioid | 28 | 2026 | 1167 | 2.200 |
Why?
| | Registries | 31 | 2025 | 2434 | 1.680 |
Why?
| | Emergency Service, Hospital | 26 | 2026 | 2416 | 1.440 |
Why?
| | Methanol | 4 | 2021 | 44 | 1.430 |
Why?
| | Ethylene Glycol | 5 | 2022 | 15 | 1.270 |
Why?
| | Antidotes | 8 | 2023 | 145 | 1.260 |
Why?
| | Acidosis | 3 | 2022 | 107 | 1.010 |
Why?
| | Tramadol | 6 | 2024 | 17 | 0.960 |
Why?
| | Cannabinoids | 3 | 2022 | 184 | 0.860 |
Why?
| | Cocaine | 3 | 2026 | 162 | 0.850 |
Why?
| | Decontamination | 2 | 2014 | 28 | 0.790 |
Why?
| | Burns, Chemical | 2 | 2014 | 33 | 0.780 |
Why?
| | Bias | 1 | 2024 | 201 | 0.780 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 7 | 2018 | 267 | 0.760 |
Why?
| | Snake Bites | 5 | 2022 | 24 | 0.760 |
Why?
| | Butterflies | 1 | 2023 | 21 | 0.750 |
Why?
| | Opiate Alkaloids | 1 | 2022 | 6 | 0.740 |
Why?
| | Mesothelioma | 1 | 2023 | 52 | 0.740 |
Why?
| | Moths | 1 | 2023 | 45 | 0.730 |
Why?
| | Substance-Related Disorders | 7 | 2025 | 1112 | 0.720 |
Why?
| | Poisons | 1 | 2021 | 20 | 0.680 |
Why?
| | Fentanyl | 6 | 2024 | 128 | 0.680 |
Why?
| | Drug Contamination | 3 | 2026 | 56 | 0.680 |
Why?
| | Pyrazoles | 4 | 2021 | 518 | 0.640 |
Why?
| | Cobalt | 2 | 2017 | 50 | 0.610 |
Why?
| | Hip Prosthesis | 2 | 2017 | 42 | 0.610 |
Why?
| | Benzodiazepines | 4 | 2025 | 169 | 0.610 |
Why?
| | Abortion, Induced | 1 | 2022 | 113 | 0.610 |
Why?
| | Referral and Consultation | 9 | 2025 | 886 | 0.580 |
Why?
| | Central Nervous System Stimulants | 3 | 2025 | 187 | 0.580 |
Why?
| | Skin | 2 | 2014 | 759 | 0.560 |
Why?
| | Metformin | 1 | 2022 | 329 | 0.540 |
Why?
| | United States | 34 | 2026 | 16313 | 0.540 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2017 | 2 | 0.530 |
Why?
| | Hypoglycemia | 2 | 2022 | 489 | 0.520 |
Why?
| | Chromium | 1 | 2017 | 18 | 0.520 |
Why?
| | Humans | 86 | 2026 | 147293 | 0.520 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2017 | 187 | 0.510 |
Why?
| | Suicide, Attempted | 6 | 2025 | 430 | 0.500 |
Why?
| | Prospective Studies | 23 | 2026 | 8164 | 0.500 |
Why?
| | Adult | 48 | 2026 | 41405 | 0.490 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 2 | 2026 | 28 | 0.460 |
Why?
| | Substance Abuse Detection | 5 | 2026 | 112 | 0.460 |
Why?
| | Chelating Agents | 3 | 2021 | 76 | 0.450 |
Why?
| | Middle Aged | 40 | 2026 | 36821 | 0.450 |
Why?
| | Chelation Therapy | 2 | 2013 | 10 | 0.430 |
Why?
| | Opioid-Related Disorders | 4 | 2026 | 617 | 0.420 |
Why?
| | Mercury Poisoning, Nervous System | 1 | 2013 | 2 | 0.410 |
Why?
| | Young Adult | 27 | 2026 | 14437 | 0.400 |
Why?
| | Male | 52 | 2026 | 73950 | 0.390 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 65 | 0.390 |
Why?
| | Self-Injurious Behavior | 2 | 2025 | 143 | 0.390 |
Why?
| | Bupropion | 2 | 2024 | 48 | 0.380 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1107 | 0.380 |
Why?
| | Inappropriate Prescribing | 1 | 2013 | 66 | 0.380 |
Why?
| | Decision Support Techniques | 1 | 2017 | 480 | 0.360 |
Why?
| | Female | 51 | 2026 | 80076 | 0.350 |
Why?
| | Antivenins | 4 | 2022 | 29 | 0.350 |
Why?
| | Paraquat | 1 | 2011 | 13 | 0.350 |
Why?
| | Narcotic Antagonists | 6 | 2025 | 210 | 0.350 |
Why?
| | Naloxone | 8 | 2025 | 138 | 0.340 |
Why?
| | Herbicides | 1 | 2011 | 27 | 0.340 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 43 | 0.340 |
Why?
| | Hallucinogens | 2 | 2023 | 112 | 0.310 |
Why?
| | Analgesics, Non-Narcotic | 3 | 2023 | 131 | 0.300 |
Why?
| | Methadone | 3 | 2020 | 131 | 0.300 |
Why?
| | Pharmacovigilance | 3 | 2024 | 25 | 0.300 |
Why?
| | Child | 24 | 2025 | 22979 | 0.280 |
Why?
| | Aged | 19 | 2023 | 26514 | 0.280 |
Why?
| | Levamisole | 2 | 2026 | 22 | 0.280 |
Why?
| | Xylazine | 2 | 2026 | 16 | 0.280 |
Why?
| | Adolescent | 23 | 2025 | 22825 | 0.270 |
Why?
| | Bradycardia | 2 | 2026 | 63 | 0.270 |
Why?
| | Time Factors | 9 | 2025 | 7173 | 0.250 |
Why?
| | Child, Preschool | 17 | 2025 | 12016 | 0.250 |
Why?
| | Medetomidine | 1 | 2026 | 4 | 0.240 |
Why?
| | Adenosine Monophosphate | 2 | 2024 | 88 | 0.230 |
Why?
| | Alanine | 2 | 2024 | 173 | 0.230 |
Why?
| | Edema | 2 | 2023 | 128 | 0.220 |
Why?
| | Cannabis | 2 | 2023 | 518 | 0.210 |
Why?
| | Treatment Outcome | 10 | 2020 | 11947 | 0.210 |
Why?
| | Patient Outcome Assessment | 1 | 2025 | 130 | 0.210 |
Why?
| | Seizures | 3 | 2021 | 491 | 0.210 |
Why?
| | Intubation, Intratracheal | 2 | 2025 | 329 | 0.210 |
Why?
| | Infant | 13 | 2025 | 10194 | 0.210 |
Why?
| | Plant Poisoning | 1 | 2023 | 8 | 0.200 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2023 | 29 | 0.200 |
Why?
| | Talc | 1 | 2023 | 9 | 0.190 |
Why?
| | Cohort Studies | 10 | 2024 | 6099 | 0.190 |
Why?
| | Metals, Heavy | 2 | 2021 | 31 | 0.190 |
Why?
| | Predictive Value of Tests | 4 | 2017 | 2133 | 0.190 |
Why?
| | Anticonvulsants | 3 | 2022 | 253 | 0.190 |
Why?
| | Amphetamines | 1 | 2022 | 6 | 0.190 |
Why?
| | Psychotropic Drugs | 4 | 2023 | 79 | 0.180 |
Why?
| | Prescription Drug Misuse | 2 | 2021 | 53 | 0.180 |
Why?
| | Diphenhydramine | 1 | 2022 | 36 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 417 | 0.180 |
Why?
| | Ivermectin | 1 | 2022 | 15 | 0.180 |
Why?
| | Foodborne Diseases | 1 | 2023 | 60 | 0.180 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2025 | 294 | 0.180 |
Why?
| | Snakes | 2 | 2022 | 19 | 0.180 |
Why?
| | Narcotics | 1 | 2022 | 58 | 0.180 |
Why?
| | Caffeine | 1 | 2022 | 76 | 0.180 |
Why?
| | Larva | 1 | 2023 | 242 | 0.180 |
Why?
| | Sulfonylurea Compounds | 1 | 2022 | 51 | 0.170 |
Why?
| | Vertigo | 1 | 2022 | 55 | 0.170 |
Why?
| | Nausea | 1 | 2022 | 112 | 0.170 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 65 | 0.170 |
Why?
| | Acetaminophen | 2 | 2022 | 269 | 0.170 |
Why?
| | Tremor | 1 | 2022 | 98 | 0.170 |
Why?
| | Vomiting | 1 | 2022 | 131 | 0.170 |
Why?
| | Dizziness | 1 | 2022 | 101 | 0.170 |
Why?
| | Diarrhea | 1 | 2022 | 193 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 506 | 0.160 |
Why?
| | Coral Snakes | 1 | 2020 | 3 | 0.160 |
Why?
| | Abdominal Pain | 1 | 2022 | 149 | 0.160 |
Why?
| | Elapid Venoms | 1 | 2020 | 14 | 0.160 |
Why?
| | Research Personnel | 4 | 2022 | 187 | 0.160 |
Why?
| | Analgesics | 1 | 2022 | 231 | 0.160 |
Why?
| | Eating | 1 | 2023 | 387 | 0.160 |
Why?
| | Crotalus | 1 | 2020 | 24 | 0.150 |
Why?
| | Patient-Centered Care | 1 | 2025 | 552 | 0.150 |
Why?
| | Crotalid Venoms | 1 | 2020 | 30 | 0.150 |
Why?
| | Creatinine | 1 | 2022 | 516 | 0.150 |
Why?
| | Risk Factors | 7 | 2024 | 11017 | 0.150 |
Why?
| | Rhabdomyolysis | 1 | 2019 | 24 | 0.150 |
Why?
| | Nicotine | 1 | 2022 | 336 | 0.150 |
Why?
| | Blood Chemical Analysis | 2 | 2010 | 109 | 0.150 |
Why?
| | Heavy Metal Poisoning | 2 | 2021 | 3 | 0.150 |
Why?
| | Antidiarrheals | 1 | 2018 | 12 | 0.140 |
Why?
| | Loperamide | 1 | 2018 | 12 | 0.140 |
Why?
| | Antidepressive Agents | 3 | 2016 | 245 | 0.140 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2019 | 75 | 0.140 |
Why?
| | Prevalence | 3 | 2024 | 2889 | 0.140 |
Why?
| | Annual Reports as Topic | 1 | 2018 | 2 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 442 | 0.140 |
Why?
| | Crime | 1 | 2019 | 58 | 0.140 |
Why?
| | Biomedical Research | 1 | 2025 | 723 | 0.140 |
Why?
| | Retrospective Studies | 7 | 2024 | 17560 | 0.140 |
Why?
| | Viperidae | 1 | 2018 | 6 | 0.140 |
Why?
| | Animals | 10 | 2023 | 38410 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 740 | 0.140 |
Why?
| | Length of Stay | 3 | 2025 | 1371 | 0.140 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2018 | 56 | 0.130 |
Why?
| | Biomarkers | 4 | 2022 | 4351 | 0.130 |
Why?
| | Israel | 2 | 2017 | 46 | 0.130 |
Why?
| | Hospital Mortality | 4 | 2025 | 1043 | 0.130 |
Why?
| | Drug Misuse | 1 | 2017 | 2 | 0.130 |
Why?
| | London | 1 | 2017 | 46 | 0.130 |
Why?
| | Renal Insufficiency | 1 | 2019 | 172 | 0.130 |
Why?
| | Prognosis | 4 | 2022 | 4383 | 0.130 |
Why?
| | Hospitalization | 5 | 2025 | 2496 | 0.120 |
Why?
| | Aged, 80 and over | 7 | 2019 | 8430 | 0.120 |
Why?
| | Bicarbonates | 2 | 2022 | 45 | 0.120 |
Why?
| | Neurologic Examination | 1 | 2017 | 132 | 0.120 |
Why?
| | Prosthesis Failure | 1 | 2017 | 127 | 0.120 |
Why?
| | Pediatrics | 3 | 2018 | 1139 | 0.120 |
Why?
| | Designer Drugs | 1 | 2016 | 7 | 0.120 |
Why?
| | Brain Death | 1 | 2017 | 60 | 0.120 |
Why?
| | Crime Victims | 1 | 2019 | 133 | 0.120 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2018 | 185 | 0.120 |
Why?
| | Disease Outbreaks | 1 | 2019 | 420 | 0.120 |
Why?
| | North America | 3 | 2022 | 307 | 0.110 |
Why?
| | Odds Ratio | 1 | 2017 | 1084 | 0.110 |
Why?
| | Chronic Pain | 1 | 2019 | 301 | 0.100 |
Why?
| | Heroin | 2 | 2026 | 30 | 0.100 |
Why?
| | Pregnancy | 3 | 2023 | 7274 | 0.100 |
Why?
| | Body Burden | 1 | 2013 | 7 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 226 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 880 | 0.100 |
Why?
| | Hydrofluoric Acid | 1 | 2013 | 7 | 0.100 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 196 | 0.100 |
Why?
| | Poison Control Centers | 2 | 2015 | 85 | 0.100 |
Why?
| | Urinalysis | 1 | 2013 | 83 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 54 | 0.100 |
Why?
| | Chromatography, Liquid | 2 | 2025 | 453 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2024 | 151 | 0.100 |
Why?
| | International Cooperation | 1 | 2013 | 198 | 0.090 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3448 | 0.090 |
Why?
| | Data Mining | 1 | 2013 | 114 | 0.090 |
Why?
| | Australia | 1 | 2013 | 299 | 0.090 |
Why?
| | Organic Chemicals | 1 | 2013 | 113 | 0.090 |
Why?
| | Ethanol | 2 | 2023 | 634 | 0.090 |
Why?
| | Canada | 1 | 2013 | 435 | 0.090 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1415 | 0.090 |
Why?
| | Sentinel Surveillance | 2 | 2026 | 48 | 0.090 |
Why?
| | Coma | 2 | 2023 | 39 | 0.090 |
Why?
| | Renal Dialysis | 2 | 2019 | 467 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 571 | 0.080 |
Why?
| | Glycols | 1 | 2010 | 5 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2013 | 471 | 0.080 |
Why?
| | Ethylenes | 1 | 2010 | 16 | 0.080 |
Why?
| | Ethylene Glycols | 1 | 2010 | 17 | 0.080 |
Why?
| | Consultants | 1 | 2010 | 12 | 0.080 |
Why?
| | Compensation and Redress | 1 | 2010 | 8 | 0.080 |
Why?
| | Water | 1 | 2013 | 452 | 0.080 |
Why?
| | Half-Life | 1 | 2010 | 157 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2010 | 198 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 742 | 0.080 |
Why?
| | Blood Glucose | 1 | 2020 | 2359 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 606 | 0.070 |
Why?
| | Disease Progression | 2 | 2023 | 2890 | 0.070 |
Why?
| | Societies, Medical | 1 | 2013 | 914 | 0.070 |
Why?
| | Osmolar Concentration | 1 | 2009 | 168 | 0.070 |
Why?
| | Buprenorphine | 2 | 2025 | 201 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2973 | 0.070 |
Why?
| | HIV Infections | 1 | 2024 | 3235 | 0.070 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1072 | 0.070 |
Why?
| | Infant, Newborn | 3 | 2020 | 6543 | 0.070 |
Why?
| | Survivors | 1 | 2011 | 528 | 0.070 |
Why?
| | Databases, Factual | 3 | 2017 | 1504 | 0.060 |
Why?
| | Missouri | 1 | 2024 | 67 | 0.050 |
Why?
| | Pennsylvania | 1 | 2024 | 138 | 0.050 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2024 | 46 | 0.050 |
Why?
| | Outpatients | 2 | 2021 | 450 | 0.050 |
Why?
| | Amines | 1 | 2023 | 40 | 0.050 |
Why?
| | Health Personnel | 1 | 2010 | 762 | 0.050 |
Why?
| | Alcoholism | 1 | 2010 | 838 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 224 | 0.050 |
Why?
| | Inpatients | 2 | 2021 | 556 | 0.050 |
Why?
| | Phenacetin | 1 | 2022 | 1 | 0.050 |
Why?
| | Lactic Acid | 1 | 2024 | 295 | 0.050 |
Why?
| | Alprazolam | 1 | 2022 | 6 | 0.050 |
Why?
| | Codeine | 1 | 2022 | 7 | 0.050 |
Why?
| | Glycolates | 1 | 2022 | 6 | 0.050 |
Why?
| | Risk Assessment | 3 | 2019 | 3784 | 0.040 |
Why?
| | Sucrose | 1 | 2022 | 114 | 0.040 |
Why?
| | Chloroquine | 1 | 2022 | 54 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2023 | 208 | 0.040 |
Why?
| | Age Factors | 2 | 2020 | 3372 | 0.040 |
Why?
| | Quercetin | 1 | 2021 | 20 | 0.040 |
Why?
| | Patient Participation | 1 | 2025 | 449 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1220 | 0.040 |
Why?
| | Diazepam | 1 | 2021 | 33 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2009 | 1598 | 0.040 |
Why?
| | Benzimidazoles | 1 | 2022 | 190 | 0.040 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 44 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 6011 | 0.040 |
Why?
| | Paresthesia | 1 | 2020 | 14 | 0.040 |
Why?
| | Erythema | 1 | 2020 | 28 | 0.040 |
Why?
| | Antiemetics | 1 | 2020 | 51 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2021 | 450 | 0.040 |
Why?
| | Iron | 1 | 2022 | 361 | 0.040 |
Why?
| | Emergency Treatment | 1 | 2021 | 123 | 0.040 |
Why?
| | Texas | 1 | 2020 | 278 | 0.040 |
Why?
| | Alcoholic Beverages | 1 | 2019 | 32 | 0.040 |
Why?
| | Research Design | 1 | 2025 | 1157 | 0.040 |
Why?
| | Weapons of Mass Destruction | 1 | 2018 | 1 | 0.040 |
Why?
| | Atrioventricular Block | 1 | 2018 | 44 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2024 | 776 | 0.030 |
Why?
| | Long QT Syndrome | 1 | 2018 | 68 | 0.030 |
Why?
| | Retreatment | 1 | 2017 | 80 | 0.030 |
Why?
| | Demography | 1 | 2018 | 283 | 0.030 |
Why?
| | Toxiferine | 1 | 2016 | 1 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 907 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 330 | 0.030 |
Why?
| | Triage | 1 | 2019 | 250 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 172 | 0.030 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 198 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2016 | 50 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 381 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 360 | 0.030 |
Why?
| | Patient Admission | 1 | 2017 | 220 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 915 | 0.030 |
Why?
| | Electrocardiography | 1 | 2018 | 675 | 0.030 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 69 | 0.030 |
Why?
| | Pain | 1 | 2020 | 794 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1720 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 99 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4591 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 367 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 952 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5613 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 1049 | 0.020 |
Why?
| | Oxycodone | 1 | 2012 | 52 | 0.020 |
Why?
| | Device Removal | 1 | 2013 | 149 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3660 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2012 | 139 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2218 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2013 | 363 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 166 | 0.020 |
Why?
| | Health Promotion | 1 | 2017 | 792 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 2012 | 211 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 874 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 652 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2015 | 691 | 0.020 |
Why?
| | Incidence | 1 | 2012 | 2954 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 6164 | 0.010 |
Why?
|
|
Brent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|